1 1

Medical Education Hub

Cedars Sinai Research Updates in Lymphoma 2024

Cedars Sinai Research Updates in Lymphoma 2024

€10,00 EUR
€10,00 EUR
Sale Sold out
Taxes included. Shipping calculated at checkout.

Cedars Sinai Research Updates in Lymphoma 2024

Include: 2 videos + 13 pdfs, size: 2.58 GB
Target Audience: hematologists, oncologists, internal medicine specialists, pathologists
Information:


Date & Location: Saturday, September 28, 2024, 8:30 AM – Sunday, September 29, 2024, 2:00 PM PST, Cedars-Sinai Advanced Health Science Pavilion Educational Center, Los Angeles, CA

Target Audience
Specialties – Hematology, Imaging, Internal Medicine, Oncology, Pathology & Laboratory Medicine, Radiation Oncology, Radiology, Surgery
Professions – Nurse, Nurse (Advanced Practice NP CRNA CNM CNS), Physician, Researcher (non-physician), Researcher (physician)
Overview

This conference will provide a chance for Southern California lymphoma specialists and national experts to gather and discuss updates and advancements in lymphoma treatment and research. The clinical updates sessions will highlight newly approved therapies and those in the pipeline. Case based, “How I Treat” sessions will address questions of sequencing therapies and patients selection. The scientific sessions will present high impact basic science with high translational relevance, such as new biomarkers, therapeutic targets and novel cellular therapies.
Objectives
  1. Recognize the utility of molecular testing in the classification and treatment of lymphoma
  2. Identify current evidence based treatments for Hodgkin lymphoma, diffuse large B-cell lymphoma, and peripheral T-cell lymphoma
  3. Describe new treatments under development including bi-specific antibodies and CART therapies

 

 Topics:
  • Genetics of Mantle Cell Lymphoma.pdf
  • Integrated single cell analysis reveals co-evolution of malignant B cells and tumor micro-environment in transformed follicular lymphoma.pdf
  • Integrative genomic analysis identifies DLBCL immune environments associated with bispecific antibody response.pdf
  • KEYNOTE Cell Free DNA in Lymphoma.pdf
  • Ligand Receptor Cross talk in Hodgkin lymphoma.pdf
  • Mathematical modeling to generate testable hypotheses from spatial profiling data.pdf
  • Novel treatments for Hodgkin and T cell lymphoma.pdf
  • Pathology Updates What’s new with WHO classification.pdf
  • September 28.mp4
  • September 29.mp4
  • SUMOylation regulates T cell exhaustion in lymphoma.pdf
  • Transformation in CLL.pdf
  • Unexpected Metabolic Reprogramming in CAR-T Cells.pdf
  • Updates in B-cell Lymphoma.pdf
  • Using organoids to model follicular Lymphoma.pdf
View full details